Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - asciminib hydrochloride, quantity: 21.62 mg (equivalent: asciminib, qty 20 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; xanthan gum; titanium dioxide; lactose monohydrate; hyprolose; lecithin; microcrystalline cellulose; iron oxide red; iron oxide yellow; croscarmellose sodium; purified talc; polyvinyl alcohol - scemblix is indicated for the treatment of patients 18 years of age and above with: ? philadelphia chromosome-positive chronic myeloid leukaemia (ph+ cml) in chronic phase (cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.1 clinical trials). ? ph+ cml in cp with the t315i mutation.

Japonsko - angličtina - すりの適正使用協議会 RAD-AR Council, Japan

toa eiyo ltd. - bepridil hydrochloride hydrate - white tablet with split line, diameter: 8.0 mm, thickness: 3.7 mm

Japonsko - angličtina - すりの適正使用協議会 RAD-AR Council, Japan

toa eiyo ltd. - bepridil hydrochloride hydrate - white tablet with split line, diameter: 6.0 mm, thickness: 3.2 mm

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - labetalol hydrochloride 100mg;  ; labetalol hydrochloride 100mg - film coated tablet - 100 mg - active: labetalol hydrochloride 100mg   excipient: carnauba wax lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch sodium starch glycolate active: labetalol hydrochloride 100mg excipient: carnauba wax diethyl phthalate ethanol hypromellose e-15 lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch purified water sodium starch glycolate

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - labetalol hydrochloride 200mg;  ; labetalol hydrochloride 200mg - film coated tablet - 200 mg - active: labetalol hydrochloride 200mg   excipient: carnauba wax lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch sodium starch glycolate active: labetalol hydrochloride 200mg excipient: carnauba wax diethyl phthalate ethanol hypromellose e-15 lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch purified water sodium starch glycolate

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

viatris limited - labetalol hydrochloride 50mg;  ; labetalol hydrochloride 50mg - film coated tablet - 50 mg - active: labetalol hydrochloride 50mg   excipient: carnauba wax lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch sodium starch glycolate active: labetalol hydrochloride 50mg excipient: carnauba wax diethyl phthalate ethanol hypromellose e-15 lactose monohydrate magnesium stearate maize starch opaspray orange k-1r-2433 pregelatinised maize starch purified water sodium starch glycolate

Kanada - angličtina - Health Canada

novartis pharmaceuticals canada inc - nilotinib (nilotinib hydrochloride monohydrate) - capsule - 200mg - nilotinib (nilotinib hydrochloride monohydrate) 200mg - antineoplastic agents

Kanada - angličtina - Health Canada

novartis pharmaceuticals canada inc - nilotinib (nilotinib hydrochloride monohydrate) - capsule - 150mg - nilotinib (nilotinib hydrochloride monohydrate) 150mg - antineoplastic agents

Spojené štáty - angličtina - NLM (National Library of Medicine)

avera mckennan hospital - sotalol hydrochloride (unii: hec37c70xx) (sotalol - unii:a6d97u294i) - sotalol hydrochloride 80 mg

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - nilotinib hydrochloride monohydrate, quantity: 165.45 mg (equivalent: nilotinib, qty 150 mg) - capsule, hard - excipient ingredients: magnesium stearate; gelatin; titanium dioxide; lactose monohydrate; colloidal anhydrous silica; poloxamer; iron oxide yellow; crospovidone; iron oxide red; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; strong ammonia solution; ethanol absolute; iron oxide black; ethanol; shellac; sulfuric acid; industrial methylated spirit; ammonia - tasigna is indicated for the:,? treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (cml) in chronic phase. ? treatment of adults with chronic phase and accelerated phase philadelphia chromosome positive chronic myeloid leukaemia (cml) resistant to or intolerant of prior therapy including imatinib.